Switch to:
More From Other Websites
Ocular Therapeutix™ Announces Executive Transition Plans Jun 22 2017
ETFs with exposure to Ocular Therapeutix, Inc. : June 16, 2017 Jun 16 2017
Ocular Therapeutix, Inc. :OCUL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Jun 02 2017
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences Jun 01 2017
Ocular Therapeutix™ Presented Phase 3 Data for DEXTENZA™ at the Association for Research in... May 11 2017
Ocular Therapeutix™ Presents Preclinical Data on Pharmacokinetics, Efficacy and Tolerability of... May 09 2017
Why Ocular Therapeutix Inc Stock Jumped Higher Today May 08 2017
Betting on Adamis Pharmaceuticals and Ocular Therapeutix Ahead of FDA Decisions May 08 2017
Today's Research Reports on Stocks to Watch: ImmunoGen and Ocular Therapeutix May 08 2017
Ocular Therapeutix™ Presents Additional Phase 3 Data and Patient Reported Outcomes Results for... May 08 2017
Edited Transcript of OCUL earnings conference call or presentation 5-May-17 12:30pm GMT May 06 2017
Why Ocular Theraputix Inc. Got Hammered Today May 05 2017
Ocular Therapeutix reports 1Q loss May 05 2017
Investor Network: Ocular Therapeutix Inc to Host Earnings Call May 05 2017
Ocular Therapeutix™ Reports First Quarter 2017 Financial Results May 05 2017
Ocular Therapeutix™ to Present Data on Anterior and Posterior Segment Drug Product Candidates at... May 02 2017
Ocular Therapeutix™ to Report First Quarter 2017 Financial Results May 01 2017
ETFs with exposure to Ocular Therapeutix, Inc. : April 24, 2017 Apr 24 2017
Ocular Therapeutix™ to Present Additional Phase 3 Data and Patient Reported Outcomes Results for... Apr 24 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK